+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Self-injections Market by Type (Auto-Injectors, Needle-free Injectors, Pen Injectors), Usage (Disposable, Reusable), Distribution Channel, Therapeutic Areas Application - Forecast 2024-2030- Product Image
Global Self-injections Market by Type (Auto-Injectors, Needle-free Injectors, Pen Injectors), Usage (Disposable, Reusable), Distribution Channel, Therapeutic Areas Application - Forecast 2024-2030- Product Image
Sale

Global Self-injections Market by Type (Auto-Injectors, Needle-free Injectors, Pen Injectors), Usage (Disposable, Reusable), Distribution Channel, Therapeutic Areas Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4985960
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Self-injections Market size was estimated at USD 54.00 billion in 2023, USD 60.64 billion in 2024, and is expected to grow at a CAGR of 12.72% to reach USD 124.87 billion by 2030.

Self-injections refer to the products used to administer medication to themselves intramuscularly, subcutaneously, or intravenously without the immediate assistance of healthcare professionals. Self-injections are used for treatments that require regular and long-term care, such as insulin for diabetes, hormones for hormone replacement therapy and fertility treatments, and biologics for chronic conditions. Self-injection devices are widely used to increase autonomy and can improve treatment adherence by eliminating the need for healthcare provider administration.

An elevating prevalence of chronic diseases, the need for home-based healthcare, advancements in drug delivery technology, and a growing patient preference for self-administration have improved the usage of self-injections in recent years. However, the requirement for significant investment in research and development, patient safety and comfort concerns, and the need for cold chain storage and logistics for biologics limit the product penetration of self-injections. Recognition of digitization and patient-centricity leads to opportunities for integrating smart technology into self-injection devices. Innovations focusing on connectivity can provide data collection, patient monitoring, and adherence tracking, guiding personalized treatment modalities for self-injections. Moreover, the supportive government approvals for self-injections are further expanding the scope of the market.

Regional Insights

The self-injections market in the Americas is driven by a strong emphasis on patient-centric care, advanced healthcare infrastructure, and an increase in biologic drug approvals that require patient-friendly administration. Consumers are becoming increasingly aware of self-care options, including self-injection devices, which align with convenience. Government initiatives to reduce hospital stays and promote self-administration of medication also contribute to the penetration of self-injections in the Americas. In the European Union, market growth for self-injection devices is supported by an aging population, the prevalence of chronic diseases, and a strong inclination toward self-management of these conditions.

The EU's rigorous regulatory framework ensures high safety standards for self-injection devices. Furthermore, several EU countries have been active in running patient education programs to encourage the adoption of self-injection practices. In the Middle East and Africa, substantial investments in healthcare infrastructure and an increasing incidence of lifestyle-related diseases show promising growth for the self-injections market. In the Asia-Pacific region, rapid economic growth and increased healthcare expenditure are major drivers for the self-injections market. The government's emphasis on pharmaceutical innovation and the surging prevalence of chronic diseases are boosting demand. Furthermore, a technologically advanced healthcare system and an aging population enable the market for self-injection devices in the Asia Pacific.

Market Trends by Segment

  • Type: Rising preference for pen injectors to manage chronic diseases
  • Usage: Growing use of disposable self-injections to avoid the risk of cross-contamination
  • Distribution Channel: Emerging penetration of self-injections on online platforms
  • Therapeutic Areas Application: Growing applications of self-injections to treat hormonal issues

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Micron Biomedical Receives Funds To Produce Needle-Free Vaccines

Atlanta-based Micron Biomedical secured a substantial USD 23.6 million investment from the Bill & Melinda Gates Foundation, earmarked for scaling up the production of its revolutionary needle-free vaccines. Employing advanced microarray technology, these vaccines offer a virtually pain-free administration through a simple press of a button. This innovation simplifies the vaccination process and significantly reduces reliance on the cold chain, allowing community health workers to promptly vaccinate children, thereby expanding access to preventive care in low and middle-income regions.

Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval

Enable Injections achieved a significant milestone with the first approval from the U.S. Food and Drug Administration (FDA). The FDA's authorization marks a pivotal step forward for Enable Injections, reinforcing their commitment to advancing self-injection technology, and providing patients with innovative solutions for drug delivery. This approval, detailed in a press release, underscores the company's dedication to quality and safety in developing user-centric devices that simplify the administration of high-volume, subcutaneous injections for various therapies.

Altaviz introduces New Auto-Injector Platform For Drug Delivery

Altaviz's introduced auto-injector platform aids in revolutionizing self-administered medical treatments. This state-of-the-art system is meticulously designed to address various challenges associated with traditional injectable drug delivery, such as improving patient adherence, enhancing ease of use, and minimizing discomfort. By integrating sophisticated technologies, Altaviz's auto-injector offers a highly intuitive solution that empowers patients to manage their treatments effectively and with confidence.

Key Company Profiles

The report delves into recent significant developments in the Self-injections Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Antares Pharma, Inc. by Halozyme, Inc., AstraZeneca plc, Baxter International, Inc., Becton, Dickinson and Company, Credence MedSystems, Inc., DALI Medical Devices Ltd., Eli Lilly and Company, Enable Injections, Inc., Gerresheimer AG, GlaxoSmithKline plc, Insulet Corporation, Johnson & Johnson Services, Inc., Medmix AG by Sulzer Ltd., Merck KGaA, Molex LLC by Koch Industries, Inc., Mylan N.V. by Viatris Inc., Novo Nordisk A/S, Owen Mumford Limited, PenJet Corporation, Pfizer Inc., PharmaJet, Inc., Recipharm AB, Sanofi S.A., SCHOTT AG, SHL Medical AG, Terumo Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed Group.

This research report offers invaluable insights into various crucial aspects of the Self-injections Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rapid prevalence of chronic diseases and rheumatoid arthritis
5.1.1.2. Wide availability of self-injections for fertility treatments
5.1.2. Restraints
5.1.2.1. Potential risk of product recall
5.1.3. Opportunities
5.1.3.1. Ongoing government approvals for self-injections worldwide
5.1.3.2. Technological advancements in self-injection devices
5.1.4. Challenges
5.1.4.1. Limited awareness and administration challenges associated with self-injections
5.2. Market Segmentation Analysis
5.2.1. Type: Rising preference for pen injectors to manage chronic diseases
5.2.2. Usage: Growing use of disposable self-injections to avoid the risk of cross-contamination
5.2.3. Distribution Channel: Emerging penetration of self-injections on online platforms
5.2.4. Therapeutic Areas Application: Growing applications of self-injections to treat hormonal issues
5.3. Market Trend Analysis
5.3.1. Rising incidents of diabetes and chronic diseases creating need for self-injections in the Americas
5.3.2. Growing investment in healthcare infrastructure and innovation in self-injections devices in APAC region
5.3.3. Supportive government approvals for self-injections in the EMEA region
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework Analysis
6. Self-injections Market, by Type
6.1. Introduction
6.2. Auto-Injectors
6.3. Needle-free Injectors
6.4. Pen Injectors
6.5. Wearable Injectors
7. Self-injections Market, by Usage
7.1. Introduction
7.2. Disposable
7.3. Reusable
8. Self-injections Market, by Distribution Channel
8.1. Introduction
8.2. Hospital Pharmacies
8.3. Online Pharmacies
8.4. Private Clinics
9. Self-injections Market, by Therapeutic Areas Application
9.1. Introduction
9.2. Autoimmune Diseases
9.3. Emergency Drugs
9.4. Hormone Replacement Therapies
10. Americas Self-injections Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Self-injections Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Self-injections Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Micron Biomedical Receives Funds To Produce Needle-Free Vaccines
13.3.2. Enable Injections Receives First U.S. Food and Drug Administration (FDA) Approval
13.3.3. Altaviz introduces New Auto-Injector Platform For Drug Delivery
13.3.4. FDA Approves On-Body Injector for Self Administration of Pegcetacoplan for PNH
13.3.5. Civica Partners With Ypsomed For Insulin Injection Pen
13.3.6. Eitan Medical Completes Transition of Wearable Injectors Business
13.3.7. Coherus Announces U.S. Launch of UDENYCA Autoinjector
13.3.8. Ypsomed Enhances Self-Injection Device Platforms With Integrated Human Factors Services
13.3.9. Viridian Therapeutics Announces Partnership with Drug Delivery Innovator Enable Injections
13.3.10. US FDA Approves Tezspire For Self-Administration Using Pre-Filled Pen
13.3.11. Phillips-Medisize Expands Product Portfolio with Launch of a Pen Injector Platform Designed to Lower Pharma Costs, Risks and Market Barriers
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. SELF-INJECTIONS MARKET RESEARCH PROCESS
FIGURE 2. SELF-INJECTIONS MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SELF-INJECTIONS MARKET DYNAMICS
FIGURE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. SELF-INJECTIONS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. SELF-INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SELF-INJECTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SELF-INJECTIONS MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL SELF-INJECTIONS MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTO-INJECTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL SELF-INJECTIONS MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PEN INJECTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL SELF-INJECTIONS MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISPOSABLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL SELF-INJECTIONS MARKET SIZE, BY REUSABLE, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PRIVATE CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL SELF-INJECTIONS MARKET SIZE, BY AIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ALLERGIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL SELF-INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL SELF-INJECTIONS MARKET SIZE, BY CANCER, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL SELF-INJECTIONS MARKET SIZE, BY IRRITABLE BOWEL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PSORIASIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ANAPHYLACTIC SOCKS, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL SELF-INJECTIONS MARKET SIZE, BY MIGRAINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL SELF-INJECTIONS MARKET SIZE, BY BETA-INTERFERON, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL SELF-INJECTIONS MARKET SIZE, BY ERYTHROPOIETIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL SELF-INJECTIONS MARKET SIZE, BY FOLLICLE STIMULATING HORMONE, BY REGION, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HEPARIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL SELF-INJECTIONS MARKET SIZE, BY HEPARIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL SELF-INJECTIONS MARKET SIZE, BY INSULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL SELF-INJECTIONS MARKET SIZE, BY INSULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARATHYROID HORMONE, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARKINSON’S, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL SELF-INJECTIONS MARKET SIZE, BY PARKINSON’S, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. AMERICAS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 76. AMERICAS SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 77. AMERICAS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 78. AMERICAS SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 79. AMERICAS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 80. AMERICAS SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 81. AMERICAS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 82. AMERICAS SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 83. AMERICAS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 84. AMERICAS SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 85. AMERICAS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 86. AMERICAS SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 87. AMERICAS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 88. AMERICAS SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 89. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 90. AMERICAS SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 91. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 92. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 93. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 94. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 95. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 96. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 97. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 98. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 99. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 100. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 101. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 102. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 103. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 104. ARGENTINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 105. BRAZIL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 106. BRAZIL SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 107. BRAZIL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 108. BRAZIL SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 109. BRAZIL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 110. BRAZIL SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 111. BRAZIL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 112. BRAZIL SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 113. BRAZIL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 114. BRAZIL SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 115. BRAZIL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 116. BRAZIL SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 117. BRAZIL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 118. BRAZIL SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 119. CANADA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 120. CANADA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 121. CANADA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 122. CANADA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 123. CANADA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 124. CANADA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 125. CANADA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. CANADA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. CANADA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 128. CANADA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 129. CANADA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 130. CANADA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 131. CANADA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 132. CANADA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 133. MEXICO SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 134. MEXICO SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 135. MEXICO SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 136. MEXICO SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 137. MEXICO SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 138. MEXICO SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 139. MEXICO SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 140. MEXICO SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 141. MEXICO SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 142. MEXICO SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 143. MEXICO SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 144. MEXICO SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 145. MEXICO SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 146. MEXICO SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 147. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 148. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 149. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 150. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 151. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 152. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 153. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 154. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 155. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 156. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 157. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 158. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 159. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 160. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 161. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 162. UNITED STATES SELF-INJECTIONS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 163. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 164. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 165. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 166. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 167. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 168. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 169. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 172. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 174. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 176. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 177. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 178. ASIA-PACIFIC SELF-INJECTIONS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 179. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 180. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 181. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 182. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 183. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 184. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 185. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 186. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 187. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 188. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 189. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 190. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 191. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 192. AUSTRALIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 193. CHINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 194. CHINA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195. CHINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 196. CHINA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 197. CHINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 198. CHINA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 199. CHINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. CHINA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. CHINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 202. CHINA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 203. CHINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 204. CHINA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 205. CHINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 206. CHINA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 207. INDIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 208. INDIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 209. INDIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 210. INDIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 211. INDIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 212. INDIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 213. INDIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 214. INDIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 215. INDIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 216. INDIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 217. INDIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 218. INDIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 219. INDIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 220. INDIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 221. INDONESIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 222. INDONESIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 223. INDONESIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 224. INDONESIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 225. INDONESIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 226. INDONESIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 227. INDONESIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 228. INDONESIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 229. INDONESIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 230. INDONESIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 231. INDONESIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 232. INDONESIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 233. INDONESIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 234. INDONESIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 235. JAPAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 236. JAPAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237. JAPAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 238. JAPAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 239. JAPAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 240. JAPAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 241. JAPAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. JAPAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. JAPAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 244. JAPAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 245. JAPAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 246. JAPAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 247. JAPAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 248. JAPAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 249. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 250. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 251. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 252. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 253. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 254. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 255. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 256. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 257. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 258. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 259. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 260. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 261. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 262. MALAYSIA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 263. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 266. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 267. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 268. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 269. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 270. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 271. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 272. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 273. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 274. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 275. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 276. PHILIPPINES SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 277. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 278. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 280. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 281. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 282. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 283. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 286. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 287. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 288. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 289. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 290. SINGAPORE SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 291. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 292. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 293. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 294. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 295. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 296. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 297. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 298. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 299. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 300. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 301. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 302. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 303. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 304. SOUTH KOREA SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 305. TAIWAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 306. TAIWAN SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 307. TAIWAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 308. TAIWAN SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 309. TAIWAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 310. TAIWAN SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 311. TAIWAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 312. TAIWAN SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 313. TAIWAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 314. TAIWAN SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 315. TAIWAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 316. TAIWAN SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 317. TAIWAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 318. TAIWAN SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 319. THAILAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 320. THAILAND SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 321. THAILAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 322. THAILAND SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 323. THAILAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 324. THAILAND SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 325. THAILAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 326. THAILAND SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 327. THAILAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 328. THAILAND SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 329. THAILAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 330. THAILAND SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-2030 (USD MILLION)
TABLE 331. THAILAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2018-2023 (USD MILLION)
TABLE 332. THAILAND SELF-INJECTIONS MARKET SIZE, BY HORMONE REPLACEMENT THERAPIES, 2024-2030 (USD MILLION)
TABLE 333. VIETNAM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 334. VIETNAM SELF-INJECTIONS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 335. VIETNAM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2018-2023 (USD MILLION)
TABLE 336. VIETNAM SELF-INJECTIONS MARKET SIZE, BY USAGE, 2024-2030 (USD MILLION)
TABLE 337. VIETNAM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 338. VIETNAM SELF-INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 339. VIETNAM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2018-2023 (USD MILLION)
TABLE 340. VIETNAM SELF-INJECTIONS MARKET SIZE, BY THERAPEUTIC AREAS APPLICATION, 2024-2030 (USD MILLION)
TABLE 341. VIETNAM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2023 (USD MILLION)
TABLE 342. VIETNAM SELF-INJECTIONS MARKET SIZE, BY AUTOIMMUNE DISEASES, 2024-2030 (USD MILLION)
TABLE 343. VIETNAM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2018-2023 (USD MILLION)
TABLE 344. VIETNAM SELF-INJECTIONS MARKET SIZE, BY EMERGENCY DRUGS, 2024-203

Companies Mentioned

  • AbbVie Inc.
  • Antares Pharma, Inc. by Halozyme, Inc.
  • AstraZeneca plc
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Credence MedSystems, Inc.
  • DALI Medical Devices Ltd.
  • Eli Lilly and Company
  • Enable Injections, Inc.
  • Gerresheimer AG
  • GlaxoSmithKline plc
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medmix AG by Sulzer Ltd.
  • Merck KGaA
  • Molex LLC by Koch Industries, Inc.
  • Mylan N.V. by Viatris Inc.
  • Novo Nordisk A/S
  • Owen Mumford Limited
  • PenJet Corporation
  • Pfizer Inc.
  • PharmaJet, Inc.
  • Recipharm AB
  • Sanofi S.A.
  • SCHOTT AG
  • SHL Medical AG
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Ypsomed Group

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 60.64 Billion
Forecasted Market Value ( USD ) by 2030 $ 124.87 Billion
Compound Annual Growth Rate12.7%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Self-Injections Global Market Report 2024 - Product Image

Self-Injections Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Global Injection Pen Market: Analysis By Type, By Therapy, By End User, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028 - Product Image

Global Injection Pen Market: Analysis By Type, By Therapy, By End User, By Region Size & Forecast with Impact Analysis of COVID-19 and Forecast up to 2028

  • Report
  • 164 Pages
  • Global
From
Global Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Blood Factors, Cytokines, Immunoglobulin), Injection Routes, Application - Forecast 2024-2030 - Product Image

Global Injectable Drugs Market by Molecule Type (Large Molecule, Small Molecule), Drug Class (Blood Factors, Cytokines, Immunoglobulin), Injection Routes, Application - Forecast 2024-2030

  • Report
  • 186 Pages
  • Global
From
Global Pen Needles Market by Product (Safety Pen Needles, Standard Pen Needles), Length (10mm, 12mm, 4mm), Application, Mode of Purchase, Sales Channel, End-Use - Forecast 2024-2030 - Product Image

Global Pen Needles Market by Product (Safety Pen Needles, Standard Pen Needles), Length (10mm, 12mm, 4mm), Application, Mode of Purchase, Sales Channel, End-Use - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Wearable Injectors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Wearable Injectors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From

About the Self Injectable Device Market

The Self Injectable Device market is a subset of the Home Testing and Home Healthcare industry. It includes products such as auto-injectors, pre-filled syringes, and pen injectors, which are used to deliver medications to patients in their own homes. These devices are designed to be easy to use and provide accurate dosing, allowing patients to self-administer their medications without the need for a healthcare professional. Self Injectable Devices are becoming increasingly popular due to their convenience and cost-effectiveness. The Self Injectable Device market is highly competitive, with a number of companies offering products for a variety of medical conditions. Some of the major players in the market include Becton Dickinson, Novo Nordisk, Sanofi, Eli Lilly, and Pfizer. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.